Cargando…
Treatment of LADA With Etanercept
Autores principales: | Montes, Vince N., Hirsch, Irl B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329849/ https://www.ncbi.nlm.nih.gov/pubmed/22517944 http://dx.doi.org/10.2337/dc12-0128 |
Ejemplares similares
-
Diabetes Treatment and Cardiovascular Safety
por: Bloomgarden, Zachary T.
Publicado: (2011) -
Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276
por: Rossen, Niklas B., et al.
Publicado: (2011) -
Liraglutide Treatment in a Patient With HIV and Uncontrolled Insulin-Treated Type 2 Diabetes
por: Diamant, Michaela, et al.
Publicado: (2012) -
Lipoatrophy in a Girl With Type 1 Diabetes: Beneficial Effects of Treatment With a Glucocorticoid Added to an Insulin Analog
por: Swelheim, Hester T., et al.
Publicado: (2012) -
Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
por: Yanai, Hidekatsu, et al.
Publicado: (2011)